I have 22 consecutive profitable trades of 15% or better. How is this possible? Every day there are hundreds of stocks setting new highs, no matter what happens in the overall market. Many of these stocks are still at very reasonable valuations. Afraid of buying stocks at their highs? Think of it this way: a new high is really a future floor for companies with solid financial underpinnings. Quantitative momentum modeling makes it easy to identify stocks that can continue this upward momentum trend. Why does this happen? It's really very simple..ask me about what investors and cows have in common. I am $$$ MR. MARKET $$$. I AM HUGE!!! Bring me your finest meats and cheeses. You can join in on the fun. Register for free and you'll be able to post messages on this forum and also receive emails when $$$ MR. MARKET $$$ makes his own trades. ($$$MR. MARKET$$$ is a proprietary investor and does not provide individual financial advice. The stocks mentioned on this forum do not represent individual buy or sell recommendations and should not be viewed as such. Individual investors should consider speaking with a professional investment adviser before making any investment decisions.)
If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
River "BIO TECH" Professor Emeritus......What do you know of PROT it appears to be breaking out from here?
This is the reason.
HAWTHORNE, NJ--(Marketwire - Mar 19, 2012) - Proteonomix, Inc. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announces the completion of a previously announced $3.8 million private placement. The Company plans to use the proceeds from this financing to repay debt, fund clinical and preclinical studies and expand its management team, as well as for general corporate purposes.
This company is in its infancy with respect to its pipeline. YAWN. Long long wait with mucho results risk. No significant catalysts on the horizon. Not one for me, fer sure! ("Emeritus"?????)
davidmarisDavid Maris
@
adamfeuerstein $CRIS +10% in the past 5 days before announcement vs. a flat market - pops on the announcement, then sells off #interesting
adamfeuersteinAdam Feuerstein
Roche struck early licensing deals w. $CRIS and $IMGN when both were young and kinda desperate -- only pay out small royalty streams.
20 hours ago FavoriteRetweetReply
BioRunUpBioRunUp
Why $CRIS is selling off? $10M milestone and "a low-to-mid single digit royalty." $377M Mkt Cap on this stock...
GekkowireGekkoWire
To be precise $CRIS gets "a low-to-mid single digit royalty." How much is 3% of even the biggest blockbuster one could think of? NOT MUCH
21 hours ago FavoriteRetweetReply
GekkowireGekkoWire
$CRIS only gets single digit royalties.
21 hours ago
SuperrflySuperrfly
$CRIS everybody and their dog was in, hence the drop.
21 hours ago FavoriteRetweetReply
BioRunUpBioRunUp
$CRIS tanking.... $4.71. Dont worry everyone, Im sure @SheffStation sold at the high.
Duh! '598 patent app. allowed. Of course, it's "count Tuesday" at the PTO! The once a month the individual Examiners tally up the total action "counts" against budget and hope for bonuses! This Examiner allowed the patent app. today to boost his "count." Neat.
Speaking of BONUS, AMRN up 14% on the news! Have a sell order in at 12.45. Currently 11.93 (+14% from where I bot it late Fri).
HAWTHORNE, NJ--(Marketwire - Mar 19, 2012) - Proteonomix, Inc. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announces the completion of a previously announced $3.8 million private placement. The Company plans to use the proceeds from this financing to repay debt, fund clinical and preclinical studies and expand its management team, as well as for general corporate purposes.
This company is in its infancy with respect to its pipeline. YAWN. Long long wait with mucho results risk. No significant catalysts on the horizon. Not one for me, fer sure! ("Emeritus"?????)
Yes PROT has very low volume and any puff of bad news on the drug trials ......will make PROT drop like a rock!
The Emeritus is a Title I had bestowed on you for your thorough knowledge of many of the BIO TECH stox. Wear it in good health Take care and have a beautiful day! P7 !
Yes PROT has very low volume and any puff of bad news on the drug trials ......will make PROT drop like a rock!
The Emeritus is a Title I had bestowed on you for your thorough knowledge of many of the BIO TECH stox. Wear it in good health Take care and have a beautiful day! P7 !
Yeah, I know what it is, usually designating "retired". "You make me feel so..." um...old.
Yeah, I know what it is, usually designating "retired". "You make me feel so..." um...old.
River you are an attractive , intelligent woman ......and I never thought of the term" Emeritus" as referring to one being retired , but merely as one who is well versed in a difficult particular field.
Anyway we all love ya here ..........P7
This is an educational read about what goes on when Big Pharma tries to buy out the babies.
"(Reuters) - Biotech companies are fighting back in an unequal battle with Big Pharma, helped by a small but powerful cohort of investors who dominate the companies' share registers."
Comment